Trial intelligence / Profile preview

Metformin for progression of carotid atherosclerosis in non-diabetic cardiovascular disease

2008-002169-30Phase 4Completed

Sponsor
NHS Greater Glasgow and Clyde
Start
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in atherosclerotic disease, coronary arteriosclerosis and carotid atheroma (CAS) comparing Metformin with Placebo (2 arms). Started Oct 2008; status: completed.

02

Drugs

metformin
03

Conditions

atherosclerotic diseasecoronary arteriosclerosiscarotid atheroma (CAS)

Beyond the preview

Go deeper on 2008-002169-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002169-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call